Ovarian Reserve Testing in Female Young Adult Cancer Survivors

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

CancerInfertility

Interventions

DRUG

recombinant FSH

Each participant will recieve recombinant FSH (150 IU) intravenously

Trial Locations (1)

UCSD Moores Cancer Center, San Diego

All Listed Sponsors

lead

University of California, San Diego

OTHER